TY - JOUR
T1 - Long-Term Implications of Atrial Fibrillation in Patients With Degenerative Mitral Regurgitation
AU - MIDA Investigators
AU - Grigioni, Francesco
AU - Benfari, Giovanni
AU - Vanoverschelde, Jean Louis
AU - Tribouilloy, Christophe
AU - Avierinos, Jean Francois
AU - Bursi, Francesca
AU - Suri, Rakesh M.
AU - Guerra, Federico
AU - Pasquet, Agnés
AU - Rusinaru, Dan
AU - Marcelli, Emanuela
AU - Théron, Alexis
AU - Barbieri, Andrea
AU - Michelena, Hector
AU - Lazam, Siham
AU - Szymanski, Catherine
AU - Nkomo, Vuyisile T.
AU - Capucci, Alessandro
AU - Thapa, Prabin
AU - Enriquez-Sarano, Maurice
AU - Clavel, M. A.
AU - Maalouf, J.
AU - Trojette, F.
AU - Szymanski, C.
AU - Touati, G.
AU - Remadi, J. P.
AU - Russo, A.
AU - Biagini, E.
AU - Pasquale, F.
AU - Ferlito, M.
AU - Rapezzi, C.
AU - Savini, C.
AU - Marinelli, G.
AU - Pacini, D.
AU - Gargiulo, G. D.
AU - Di Bartolomeo, R.
AU - Boulif, J.
AU - de Meester, C.
AU - El Khoury, G.
AU - Gerber, B.
AU - Noirhomme, P.
AU - Vancraeynest, D.
AU - Collard, F.
AU - Habib, G.
AU - Mantovani, F.
AU - Lugli, R.
AU - Modena, M. G.
AU - Boriani, G.
AU - Bacchi-Reggiani, L.
N1 - Funding Information:
The present work was funded by an unrestricted grant donated by the “Fondazione del Monte di Bologna e Ravenna.” Dr. Grigioni has received payments as a board member from Sorin Group; and has received grant funding from 4Tech. Dr. Suri has received grant funding from Edwards Lifesciences, Sorin Group, and St. Jude Medical; and has received support for travel and accommodation from Sorin Group. Dr. Enriquez-Sarano served as a board member for Valtech and received grant funding from Abbott Vascular. All other authors have reported that they have no relationships relevant to the contents of this paper to disclose.
Publisher Copyright:
© 2019 American College of Cardiology Foundation
PY - 2019/1/29
Y1 - 2019/1/29
N2 - Background: Scientific guidelines consider atrial fibrillation (AF) complicating degenerative mitral regurgitation (DMR) a debated indication for surgery. Objectives: This study analyzed the prognostic/therapeutic implications of AF at DMR diagnosis and long-term. Methods: Patients were enrolled in the MIDA (Mitral Regurgitation International Database) registry, which reported the consecutive, multicenter, international experience with DMR due to flail leaflets echocardiographically diagnosed. Results: Among 2,425 patients (age 67 ± 13 years; 71% male, 67% asymptomatic, ejection fraction 64 ± 10%), 1,646 presented at diagnosis with sinus rhythm (SR), 317 with paroxysmal AD, and 462 with persistent AF. Underlying clinical/instrumental characteristics progressively worsened from SR to paroxysmal to persistent AF. During follow-up, paroxysmal and persistent AF were associated with excess mortality (10-year survival in SR and in paroxysmal and persistent AF was 74 ± 1%, 59 ± 3%, and 46 ± 2%, respectively; p < 0.0001), that persisted 20 years post-diagnosis and independently of all baseline characteristics (p values <0.0001). Surgery (n = 1,889, repair 88%) was associated with better survival versus medical management, regardless of all baseline characteristics and rhythm (adjusted hazard ratio: 0.26; 95% confidence interval: 0.23 to 0.30; p < 0.0001) but post-surgical outcome remained affected by AF (10-year post-surgical survival in SR and in paroxysmal and persistent AF was 82 ± 1%, 70 ± 4%, and 57 ± 3%, respectively; p < 0.0001). Conclusions: AF is a frequent occurrence at DMR diagnosis. Although AF is associated with older age and more severe presentation of DMR, it is independently associated with excess mortality long-term after diagnosis. Surgery is followed by improved survival in each cardiac rhythm subset, but persistence of excess risk is observed for each type of AF. Our study indicates that detection of AF, even paroxysmal, should trigger prompt consideration for surgery.
AB - Background: Scientific guidelines consider atrial fibrillation (AF) complicating degenerative mitral regurgitation (DMR) a debated indication for surgery. Objectives: This study analyzed the prognostic/therapeutic implications of AF at DMR diagnosis and long-term. Methods: Patients were enrolled in the MIDA (Mitral Regurgitation International Database) registry, which reported the consecutive, multicenter, international experience with DMR due to flail leaflets echocardiographically diagnosed. Results: Among 2,425 patients (age 67 ± 13 years; 71% male, 67% asymptomatic, ejection fraction 64 ± 10%), 1,646 presented at diagnosis with sinus rhythm (SR), 317 with paroxysmal AD, and 462 with persistent AF. Underlying clinical/instrumental characteristics progressively worsened from SR to paroxysmal to persistent AF. During follow-up, paroxysmal and persistent AF were associated with excess mortality (10-year survival in SR and in paroxysmal and persistent AF was 74 ± 1%, 59 ± 3%, and 46 ± 2%, respectively; p < 0.0001), that persisted 20 years post-diagnosis and independently of all baseline characteristics (p values <0.0001). Surgery (n = 1,889, repair 88%) was associated with better survival versus medical management, regardless of all baseline characteristics and rhythm (adjusted hazard ratio: 0.26; 95% confidence interval: 0.23 to 0.30; p < 0.0001) but post-surgical outcome remained affected by AF (10-year post-surgical survival in SR and in paroxysmal and persistent AF was 82 ± 1%, 70 ± 4%, and 57 ± 3%, respectively; p < 0.0001). Conclusions: AF is a frequent occurrence at DMR diagnosis. Although AF is associated with older age and more severe presentation of DMR, it is independently associated with excess mortality long-term after diagnosis. Surgery is followed by improved survival in each cardiac rhythm subset, but persistence of excess risk is observed for each type of AF. Our study indicates that detection of AF, even paroxysmal, should trigger prompt consideration for surgery.
KW - atrial fibrillation
KW - mitral regurgitation
KW - mitral repair
KW - percutaneous treatment
KW - prognosis
KW - surgery
UR - http://www.scopus.com/inward/record.url?scp=85059736560&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85059736560&partnerID=8YFLogxK
U2 - 10.1016/j.jacc.2018.10.067
DO - 10.1016/j.jacc.2018.10.067
M3 - Article
C2 - 30678755
AN - SCOPUS:85059736560
SN - 0735-1097
VL - 73
SP - 264
EP - 274
JO - Journal of the American College of Cardiology
JF - Journal of the American College of Cardiology
IS - 3
ER -